CorpDev.Org
Deal Intelligence Platform & Services for Global M&A / PE
Big Deal
Bain Capital Weighs $4 Billion Stake Sale in Bridge Data Centres Amid Asia’s AI Infrastructure Gold Rush
Bain Capital is exploring a partial exit from Bridge Data Centres (BDC), a Singapore-headquartered hyperscale operator, in a deal that could value the platform at more than $4 billion. The private equity titan is reportedly seeking to divest...
FIFA’s $20 Billion Commercial Pivot: Inside Infantino’s Plan to Institutionalize the World Cup
In a move that signals a fundamental restructuring of global sports governance, FIFA has moved to carve out its commercial operations into a new, for-profit entity valued at $20 billion. The initiative, spearheaded by President Gianni Infantino,...
Grant Thornton to Acquire CBIZ in $5 Billion Landmark Deal Supported by New Mountain Capital
In a transformative move for the professional services industry, Grant Thornton Advisors LLC announced on July 29, 2026, that it has entered into a definitive agreement to acquire CBIZ, Inc. (NYSE: CBZ) in an all-cash transaction valued at...
Blue Owl Weighs $30 Billion Asia Data Center Exit Amid Liquidity Pivot
Blue Owl Capital Inc. is exploring a full or partial divestment of the Asia-Pacific operations of its data center platform, Stack Infrastructure, according to people familiar with the matter. The potential transaction, which could be valued at...
The ‘Big Law’ Breach: Global Insider Trading Takedown Exposes M&A Information Vulnerabilities
TL;DR U.S. prosecutors unsealed a federal indictment on May 6, 2026, charging 30 individuals, including elite corporate attorneys, in a decade-long insider trading scheme that generated tens of millions in illicit profits. The scheme, allegedly led...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
UK Private Hospital Giant Spire Agrees to £1.03 Billion Buyout Led by Toscafund
Spire Healthcare Group agreed on September 5, 2026, to a £1.03 billion cash takeover by Tulip UK Bidco, an investment consortium led by hedge fund manager Toscafund Asset Management alongside THCP Advisory and Ares Management. The agreed offer of...
AbbVie Solidifies Immunology Dominance with $10.9 Billion Acquisition of Apogee Therapeutics
AbbVie (NYSE: ABBV) today announced the successful completion of its acquisition of Apogee Therapeutics (NASDAQ: APGE), an all-cash transaction valued at approximately $10.9 billion. Under the terms of the merger, which officially closed on...
Lilly Adds to Immune Drug Pipeline with $2.9B Merida Buyout
In a strategic maneuver to solidify its presence beyond the metabolic health sector, Eli Lilly and Company (NYSE: LLY) announced on August 31, 2026, a definitive agreement to acquire Merida Biosciences. The deal, valued at up to $2.875 billion,...
Curium Strikes $8 Billion Mega-Deal for Lantheus to Forge Global Radiopharmaceutical Powerhouse
In a definitive move to dominate the rapidly expanding nuclear medicine landscape, Curium US Holdings has entered into a definitive agreement to acquire Lantheus Holdings, Inc. (NASDAQ: LNTH) for a total consideration of up to $8.0 billion. The...
AstraZeneca Shares Tumble on Reports of $400 Billion Bristol Myers Squibb Merger Talks
AstraZeneca PLC (LON: AZN) shares fell as much as 7% in London trading on Monday, August 3, 2026, following reports that the British pharmaceutical giant has held preliminary discussions regarding a transformative merger with U.S. rival Bristol...
